Development and validation of a RP-HPLC-PDA method for simultaneous determination of lornoxicam and thiocolchicoside in pharmaceutical dosage form and its application for dissolution study

International Journal of Research in Pharmaceutical Sciences

Volumn 2, Issue 1, 2011, Pages 1-7

  Sahoo, Madhusmita ^a   Syal, Pratima ^a   Ingale, Snehal ^a   Ingale, Kunal ^a   Sindhe, Santosh ^a   Sali, Monali ^a   Choudhari, V P ^a   Kuchekar, B S ^a  

^a MAEER S MAHARASHTRA INSTITUTE OF PHARMACY   (India)

Author keywords

Column Liquid Chromatography; Dis solution; Lornoxicam; Method validation; RP HPLC PDA; Thiocolchicoside

Indexed keywords

ACETIC ACID; LORNOXICAM; METHANOL; THIOCOLCHICOSIDE;

ACCURACY; ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; FLOW RATE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET; VALIDATION STUDY;

EID: 79251581606     PISSN: None     EISSN: 09757538     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Artusi M., Santi P., ' Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies', Int. J. of Pharmaceutics, 2003, 250, pp. 203-213.
2. El-Ragehy N. A., Ellaithy M. M., El-Ghobashy M. A., 'Determination of thiocolchicoside in its binary mixtures (Thiocolchicoside_/glafenine and thiocolchicoside_/floctafenine) by TLC_/densitometry', Il Farmaco. 2003, 58, pp. 463-/468.
3. ICH-Q2B Validation of Analytical Procedures: Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 1996
4. Jadon R. S., Nayak S., Amlan S., 'Taste Masking of Lornoxicam by Polymer Carrier System and Formulation of Oral Disintegrating Tablets', Int. J. of Drug Delivery 1, 2009, pp. 27-31.
5. Mariella Artusi, Sara Nicoli, Paolo Colombo; Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro', J. of pharmaceutical sciences, 93, pp. 2431-2438
6. Martindale, The Complete Drug Reference, Thirty-sixth edition, USA, 2009, pp. 1898
7. Nemutlu E., Demircan S, Kir S, 'Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV Spectrophotometric methods', Pharmazie, 2005, 60, pp. 421-425
8. Patil K. R., Rane V. P., Sangshetti J. N., Shinde D. B., ' Stability-Indicating LC Method for Analysis of Lornoxicam in the Dosage Form', Chromatographia. 2009, 69, pp. 1001-1005.
9. Radhofer-Weltea. S., Dittrichb. P. 'Determination of the novel nonsteroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid', J. of Chrom. B. 1998, 707, pp. 151-159
10. Sutherland F. C. W., Smit M. J., ' Highly specific and sensitive liquid chromatography-tandem mass spectrometry method for the determination of 3-desmethylthiocolchicine in human plasma as analyte for the assessment of bioequivalence after oral administration of thiocolchicoside', J. of Chrom. A, 2002, 949, pp. 71-77.
11. Suwa, T., Urano, H., Shinohara, Y., and Kokatsu, J., 'Simultaneous high performance liquid chromatographic determination of lornoxicam and its 5'-hydroxy metabolite in human plasma using electrochemical detection', J. Chromatogr. 1993, 617, pp. 105-110.
12. th edn, Merk Research Laboratories, Whitehouse station. NJ. USA: 2001, pp 6, 281.
13. th edn, Merk Research Laboratories, Whitehouse station. NJ. USA: 2001, pp 1, 898.
14. Young Hoon Kim, Hye Young Ji, Eun-Seok Park, Soo-Wan Chae, and Hye Suk Lee, ' Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometric Determination of Lornoxicam in Human Plasma, Ar. Pharm Res. 2007, 30, pp. 905-910.